JCR Pharmaceuticals Email Formats
Biotechnology Research • 
Ashiya City, Hyogo, Japan • 101-200 Employees
JCR Pharmaceuticals Email Formats
JCR Pharmaceuticals uses 1 email format. The most common is {last name} (e.g., doe@jcrpharm.co.jp), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{last name} | doe@jcrpharm.co.jp | 100% |
Key Contacts at JCR Pharmaceuticals
Vanessa Tubel
Ceo
Ricarddo Cunegundes
Regional Director Medical Affairs
Claudia Tarumoto
Regional Director Of Regulatory Affairs, Quality And Pharmacovigilance
Sadia L'Baouch
Senior Director Supply Chain
Carrie Herbert
Associate Director Clinical Operations
Elvin Lee
Director And Head Of Ra Cmc
Kern Briggs
Senior Director, Business Partnerships & Strategic Communications And Head Of U.S. Operations
Jayson Perry
Director Project Management
Annamaria Muroni
Associate Director Clinical Operations
Tohru Suzuki
Associate Director / Business Development
Company overview
| Headquarters | 3-19 Kasuga-cho, Ashiya, Japan 659-0021, JP |
| Phone number | +8179732859 |
| Website | |
| NAICS | 541714 |
| Keywords | Biotechnology, Research, Cell Therapy, Technological Development, BBB, Hunter Syndrome, Hurler Syndrome, Lsds, Genetic Diseases, Mps I, Mps Ii, Blood-Brain Barrier, Lysosomal Storage Disorders, Alpha Mannosidosis, J-Brain Cargo Technology, Mps Iiia, Mucopolysaccharidosis Type 2, Mucopolysaccharidosis Type I, Next-Generation Therapies, Sanfilippo Syndrome Type A |
| Founded | 1975 |
| Employees | 101-200 |
| Socials |
About JCR Pharmaceuticals
JCR Pharmaceutical is a global specialty pharmaceuticals company that is expanding possibilities for people with rare and genetic diseases worldwide. Our core values – reliability, confidence, and belief – mean that the work we do benefits all our stakeholders, including employees, partners, and patients. We continue to build upon our 49-year legacy in Japan while expanding our global footprint with trials in the US, Europe, and Latin America. We improve patients' lives by applying our scientific expertise and unique technologies to research, develop, and deliver next-generation therapies. We are leaders in developing therapies for rare conditions, including lysosomal storage disorders (LSDs). We are building on the development work we've done in Japan to expand our LSD pipeline: Our first-in-class proprietary technology, J-Brain Cargo®, enables us to develop therapies that cross the blood-brain barrier and penetrate the central nervous system (CNS). The CNS complications of diseases are often severe, resulting in developmental delays, an impact on cognition and, above all, poor prognosis, which affect patients' independence as well as the quality of life of patients and their caregivers. With J-Brain Cargo®, we seek to address the unresolved clinical challenges of LSDs and CNS-related disorders, including neurodegeneration, neuro-oncology, and neuro-inflammation conditions, by delivering the therapy to both the body and the brain. We will continuously try to create value by our unique J-Brain Cargo® technology platform toward our corporate philosophy: “contributing towards people’s healthcare through pharmaceutical products.” In addition to the in-house research activities, we think collaborative research and development work with other companies are also important. The value of our technology platform will be increased by integrating ours with other technologies and by implementing J-Brain Cargo® within other companies’ products.
Employees by Management Level
Total employees: 101-200
Seniority
Employees
Employees by Department
JCR Pharmaceuticals has 38 employees across 9 departments.
Departments
Number of employees
Germany
Sweden
IndiaFrequently asked questions
4.8
40,000 users
